The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Kindler, Hedy
One or more keywords matched the following items that are connected to Kindler, Hedy
Item TypeName
Concept Antimetabolites, Antineoplastic
Academic Article Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.
Academic Article Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.
Academic Article Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
Academic Article Pemetrexed in pancreatic cancer.
Academic Article Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
Academic Article Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.
Academic Article Pemetrexed in patients with gastrointestinal carcinoma.
Academic Article The pemetrexed/gemcitabine combination in pancreatic cancer.
Academic Article Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
Academic Article In focus: advanced pancreatic cancer.
Academic Article Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
Academic Article The emerging role of pemetrexed for the treatment of malignant mesothelioma.
Academic Article Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Academic Article A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer.
Academic Article A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Academic Article Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).
Academic Article The role of gemcitabine in the treatment of malignant mesothelioma.
Academic Article A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
Academic Article Front-line therapy of advanced pancreatic cancer.
Academic Article Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
Search Criteria
  • Antimetabolites